Engineers Gate Manager’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
16,643
-2,703
| -14% | -$131K | 0.01% | 1228 |
|
|
2025
Q1 | $658K | Buy |
19,346
+9,176
| +90% | +$312K | 0.01% | 1309 |
|
|
2024
Q4 | $400K | Buy |
+10,170
| New | +$400K | 0.01% | 1568 |
|
|
2024
Q3 | – | Sell |
-30,982
| Closed | -$1.67M | – | 2165 |
|
|
2024
Q2 | $1.67M | Buy |
30,982
+10,062
| +48% | +$543K | 0.04% | 646 |
|
|
2024
Q1 | $1.43M | Buy |
20,920
+15,952
| +321% | +$1.09M | 0.04% | 635 |
|
|
2023
Q4 | $311K | Sell |
4,968
-426
| -8% | -$26.7K | 0.01% | 1434 |
|
|
2023
Q3 | $245K | Buy |
+5,394
| New | +$245K | 0.01% | 1410 |
|
|
2023
Q1 | – | Sell |
-9,935
| Closed | -$404K | – | 1706 |
|
|
2022
Q4 | $404K | Buy |
+9,935
| New | +$404K | 0.02% | 1028 |
|
|
2022
Q3 | – | Sell |
-17,513
| Closed | -$1.06M | – | 1694 |
|
|
2022
Q2 | $1.06M | Sell |
17,513
-1,348
| -7% | -$81.9K | 0.04% | 670 |
|
|
2022
Q1 | $1.18M | Buy |
18,861
+8,951
| +90% | +$562K | 0.05% | 554 |
|
|
2021
Q4 | $751K | Buy |
9,910
+6,884
| +227% | +$522K | 0.03% | 772 |
|
|
2021
Q3 | $339K | Sell |
3,026
-1,754
| -37% | -$196K | 0.02% | 1118 |
|
|
2021
Q2 | $774K | Buy |
+4,780
| New | +$774K | 0.05% | 557 |
|
|
2020
Q2 | – | Sell |
-20,510
| Closed | -$870K | – | 1736 |
|
|
2020
Q1 | $870K | Buy |
20,510
+9,621
| +88% | +$408K | 0.06% | 499 |
|
|
2019
Q4 | $663K | Sell |
10,889
-112
| -1% | -$6.82K | 0.03% | 845 |
|
|
2019
Q3 | $451K | Buy |
+11,001
| New | +$451K | 0.02% | 830 |
|